The Effect of Luteinizing Hormone (LH) Supplementation Following Gonadotropin-releasing Hormone (GnRH) Antagonist Administration in Advanced Reproductive Ageing Women Undergoing IVF and Embryo Transfer (IVF/ET)
Phase 4
Completed
- Conditions
- Pregnancy Result Rape
- Interventions
- Drug: Leuveris
- Registration Number
- NCT01016210
- Lead Sponsor
- The Baruch Padeh Medical Center, Poriya
- Brief Summary
To explore whether recombinant LH (rLH) supplementation (Leuveris) to recombinant follicle stimulating hormone (rFSH) following GnRH antagonist treatment has an advantage in infertile women with advanced reproductive ageing undergoing IVF-ET.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
- female candidate to IVF
- between 30-45 years old
Exclusion Criteria
- not included for fertilization
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 60 infertile women Leuveris Candidates for IVF-ET treatment
- Primary Outcome Measures
Name Time Method Pregnancy rate Starting February 2010
- Secondary Outcome Measures
Name Time Method Fertilization rate Starting February 2010 till April 2013
Trial Locations
- Locations (1)
Poriya hospital
🇮🇱Tiberias, Israel